Page images
[graphic][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][ocr errors][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed][subsumed]
[blocks in formation]

This report discusses progress and problems in the development of the Food and Drug Administration's financial disclosure system for special Government employees. Although we have issued a series of reports on financial disclosure systems for regular employees, this is our first covering special Government employees.

We made this review at the request of the Chairman, Subcommittee on Oversight and Investigations, House Committee on Interstate and Foreign Commerce. Our authority is the Budget and Accounting Act, 1921 (31 U.S.C. 53), and the Accounting and Auditing Act of 1950 (31 U.S.C. 67).

As instructed by the Chairman, we did not obtain formal comments. However, we discussed the report with the Associate Commissioner for Administration and other agency staffs in the Food and Drug Administration responsible for the financial disclosure system. We also discussed the report with officials in the Office of the General Counsel, Department of Health, Education, and Welfare. Their comments, where appropriate, were considered in this report.

We are sending copies of this report to the Director, Office of Management and Budget; and the Secretary, Health, Education, and Welfare; the Commissioner, Food and Drug Administration; and other interested parties.

Sunn R. Strate


Comptroller General
of the United States

« PreviousContinue »